Shamim Ruff, Director at REATA PHARMACEUTICALS INC (RETA), sold 16,470 shares at $164.53 ($2.7M) on 2023-07-28, disclosed to the SEC on 2023-08-01.
Scheduled sale ($2.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $164.53 | 8,235 | $1.4M | 50.0% |
| 2 | $164.53 | 8,235 | $1.4M | 50.0% |
| Total | $164.53 avg | 16,470 | $2.7M | 100% |
| Filing → |
| SRPT | SELL | 2017-10-05 | $575K | — | Filing → |
| SRPT | SELL | 2017-07-21 | $522K | — | Filing → |
| SRPT | SELL | 2016-09-30 | $439K | — | Filing → |